HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $24,843,000 | +34.4% | 939,973 | -0.6% | 2.91% | +37.5% |
| Q4 2018 | $18,486,000 | +3.0% | 946,060 | +3.2% | 2.11% | +17.5% |
| Q3 2018 | $17,956,000 | -33.6% | 917,051 | -43.8% | 1.80% | -35.0% |
| Q2 2018 | $27,029,000 | -5.2% | 1,632,212 | -18.7% | 2.77% | -21.3% |
| Q1 2018 | $28,502,000 | -0.1% | 2,007,212 | +2.7% | 3.51% | -8.9% |
| Q4 2017 | $28,542,000 | -25.1% | 1,954,912 | -35.0% | 3.86% | -20.8% |
| Q3 2017 | $38,127,000 | +32.6% | 3,006,862 | +24.1% | 4.87% | +17.9% |
| Q2 2017 | $28,750,000 | +11.1% | 2,422,090 | +38.3% | 4.13% | +0.7% |
| Q1 2017 | $25,885,000 | +128.5% | 1,751,322 | +150.2% | 4.10% | +88.8% |
| Q4 2016 | $11,326,000 | -99.8% | 700,000 | +91.8% | 2.17% | +106.6% |
| Q3 2016 | $6,617,450,000 | +108489.6% | 365,000 | -1.4% | 1.05% | -2.9% |
| Q2 2016 | $6,094,000 | +83.9% | 370,000 | +85.0% | 1.08% | +64.4% |
| Q1 2016 | $3,314,000 | +4.7% | 200,000 | +37.0% | 0.66% | +37.7% |
| Q4 2015 | $3,164,000 | – | 146,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |